New COPD drug shows promise in cutting dangerous lung attacks
Disease control
Completed
This study tested an experimental drug called astegolimab in 1334 people with chronic obstructive pulmonary disease (COPD) who had frequent flare-ups. Participants received either the drug or a placebo alongside their usual COPD treatments. The goal was to see if astegolimab coul…
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC